new warnings about reports of acute pancreatitis with sitagliptin (Januvia, Janumet)
You'll see new warnings about reports of acute pancreatitis with sitagliptin (Januvia, Janumet).
This comes on the heels of similar reports with Byetta.
Sitagliptin and Byetta (exenatide) are in different classes...but they both affect incretin hormones. This may cause pancreatic changes and inflammation that could lead to acute pancreatitis.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote